Stoke Therapeutics to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference Life Science Investing
Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering Life Science Investing
Guardant Health Announces Proposed $300.0 Million Offering of Convertible Senior Notes Due 2033 Life Science Investing
Stoke Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates Life Science Investing
BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+ in Breast and Prostate Cancer Models Biotech Investing
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing Life Science Investing
Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition Life Science Investing
